- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03240289
Texting for Diabetes Success in Pregnancy
Use of Text Messaging to Reduce Barriers to Self-care for Low-income Pregnant Women With Diabetes
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Low-income, pregnant women in the Chicago area are frequently affected by obesity or diabetes. The addition of a disease in pregnancy amplifies the requirements for optimal self-care during pregnancy. This load of information poses a significant burden, particularly for women with additional socioeconomic barriers to self-care. Preliminary work suggests patients must overcome a number of social, psychological, and knowledge-based barriers to achieve successful diabetic control in pregnancy.
This project involves development and preliminary evaluation of a patient-centered education and self-care tool for use with women whose pregnancies are complicated by diabetes. The study begins with development of a text messaging curriculum to provide motivational and educational support. We will use a one-way, non-interactive text-based educational platform to provide supportive and educational messages to a cohort of 40 women with diabetes. Women receive 3-5 text messages per week until delivery. The goal is to develop a program that can be expanded to a clinical trial in which perinatal outcomes are assessed.
The primary outcome is patient satisfaction and opinions about the texting program, as measured via a qualitative interview upon study completion. Participants underwent an enrollment survey to assess health literacy/numeracy, diabetes self-efficacy, diabetes knowledge, personality, and social hassles. They underwent a baseline in-depth one-on-one interview focusing on barriers to successful self-care with pregnancy and diabetes. Follow-up surveys and an exit interview elicited information about their opinions of the texting program. Additional goals included determining feasibility for future expansion as a trial.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Pregnant
- English-speaking
- Have gestational diabetes mellitus, type 2 diabetes mellitus, or type 1 diabetes mellitus
- Age 18 years or older
- Access to a phone that can receive text messages
Exclusion Criteria:
- Gestational age greater than 30 weeks
- Women not meeting the above inclusion criteria
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Texting
Texting group
|
Women receive text messages to aid in their diabetes self-care tasks during pregnancy; these included appointment reminders, motivational messages, and nutrition/exercise tips.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient satisfaction and feedback
Time Frame: Up to 42 weeks
|
A single qualitative interview of patient perspectives and areas for improvement in the text messaging program.
Interview takes place between 35 weeks gestation and discharge after delivery (postpartum day 2)
|
Up to 42 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Diabetes self-efficacy (Measured using the Diabetes Empowerment Scale-Short Form)
Time Frame: Up to 42 weeks
|
Assessment of diabetes self-efficacy.
Survey takes place after 35 weeks gestation and before discharge after delivery (postpartum day 2)
|
Up to 42 weeks
|
Barriers and facilitators of diabetes self-management
Time Frame: Study enrollment
|
Qualitative interview of patient experiences regarding having diabetes during pregnancy
|
Study enrollment
|
Study feasibility (as measured by number of participants retained in the study)
Time Frame: Up to 42 weeks
|
Ability to recruit and retain participants
|
Up to 42 weeks
|
Diabetes self-efficacy (Measured using the Perceived Diabetes Self-Management Scale)
Time Frame: Up to 42 weeks
|
Assessment of diabetes self-efficacy.
Survey takes place after 35 weeks gestation and before discharge after delivery (postpartum day 2)
|
Up to 42 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Melissa A Simon, MD, MPH, Northwestern University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STU00084353
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gestational Diabetes
-
IRCCS Burlo GarofoloCompletedGestational Diabetes | Gestational Diabetes Mellitus | Pregnancy-Induced Diabetes | Diabetes Mellitus, Gestational | Diabetes, Pregnancy InducedIsrael, Italy, Netherlands, Slovenia, Sri Lanka
-
UPECLIN HC FM Botucatu UnespCompletedGestational Diabetes Mellitus | Pregestational Diabetes Mellitus | Mild Gestational HyperglycemiaBrazil
-
Assistance Publique - Hôpitaux de ParisCompleted
-
University of Texas Southwestern Medical CenterCompletedMild Gestational DiabetesUnited States
-
Royal College of Surgeons, IrelandHealth Research Board, IrelandUnknownPre-Gestational Diabetes
-
University of Colorado, DenverKaiser PermanenteCompletedGestational Diabetes MellitusUnited States
-
Intermountain Health Care, Inc.Withdrawn
-
McGill University Health Centre/Research Institute...The Lawson FoundationCompletedGestational Diabetes Mellitus With Baby DeliveredCanada
-
Woman'sBaton Rouge Area FoundationCompletedGestational Diabetes MellitusUnited States
-
Baylor College of MedicineRecruitingGestational Diabetes MellitusUnited States
Clinical Trials on Texting group
-
St. Louis UniversityCompletedSMS | Education, Medical, UndergraduateUnited States
-
Linnea PolgreenNational Heart, Lung, and Blood Institute (NHLBI)CompletedHypertensionUnited States
-
University of MichiganNational Institute of Mental Health (NIMH)Active, not recruiting
-
General Committee of Teaching Hospitals and Institutes...King Saud UniversityCompletedMuscle Weakness Condition | Hand GraspSaudi Arabia
-
University of Colorado, DenverCompletedType 1 Diabetes MellitusUnited States
-
Sunnybrook Health Sciences CentreRecruiting
-
University of Illinois at Urbana-ChampaignUniversity of Minnesota; The University of The West IndiesCompleted
-
Wayne State UniversityNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)CompletedPregnancy | Marijuana UseUnited States